Renascience Inc.

TSE:4889 Stock Report

Market Cap: JP¥3.7b

Renascience Balance Sheet Health

Financial Health criteria checks 5/6

Renascience has a total shareholder equity of ¥1.6B and total debt of ¥365.0M, which brings its debt-to-equity ratio to 23%. Its total assets and total liabilities are ¥2.0B and ¥415.0M respectively.

Key information

23.0%

Debt to equity ratio

JP¥365.00m

Debt

Interest coverage ration/a
CashJP¥1.96b
EquityJP¥1.59b
Total liabilitiesJP¥415.00m
Total assetsJP¥2.00b

Recent financial health updates

Is Renascience (TSE:4889) Using Too Much Debt?

Apr 05
Is Renascience (TSE:4889) Using Too Much Debt?

Recent updates

Is Renascience (TSE:4889) Using Too Much Debt?

Apr 05
Is Renascience (TSE:4889) Using Too Much Debt?

Financial Position Analysis

Short Term Liabilities: 4889's short term assets (¥2.0B) exceed its short term liabilities (¥48.0M).

Long Term Liabilities: 4889's short term assets (¥2.0B) exceed its long term liabilities (¥367.0M).

Debt to Equity History and Analysis

Debt Level: 4889 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if 4889's debt to equity ratio has reduced over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 4889 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 4889 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 8.6% each year

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y